Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
  • Careers & studies
        • Careers & Studies

          Take the next step in your career with Centenary, Australia’s foremost clinically integrated medical research institute

          Learn more

        • Career opportunities
        • Life at Centenary
        • Post-Doctorate Research
        • PhD
        • Masters
        • Honours
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Contact
  • Donate
    Centenary Institute > News > New precision medicine laboratory to help fight cancer

New precision medicine laboratory to help fight cancer

Date time 2 December, 2021
News Type News type Media release
Prof Philip Hogg, Deputy Director of Centenary Institute and Head of ACRF Centenary Cancer Research Centre
The Centenary Institute has announced it will establish a new precision medicine laboratory, enabling world-leading research into the use of theranostics to treat cancer, thanks to a grant from the Australian Cancer Research Foundation (ACRF).

An emerging field, theranostics refers to a combined therapy and diagnostics approach to patient treatment. It involves the use of a diagnostic drug to first identify and label tumour cells – followed by the delivery of a therapeutic isotope (radioactive drug) to then kill the identified tumours.

The ACRF grant of $1.5 million, together with additional co-funding of $300,000 from Cancer Institute NSW, will be used to setup and establish the ACRF Molecular Theranostics Laboratory which will be led by Professor Philip Hogg, Head of the ACRF Centenary Cancer Research Centre.

Professor Hogg believes that the field of personalised medicine has tremendous potential for the treatment of a wide range of cancers.

“Cancer is responsible for about one in six deaths globally and the economic cost is in the trillions of dollars annually. New methods to tackle this cancer burden are greatly needed. One such method is theranostics which allows for a finely targeted search and destroy process with a therapeutic isotope delivered directly to a cancerous cell,” said Professor Hogg.

A key project to be undertaken at the laboratory by Professor Hogg is the development of a theranostic agent (called Cell Death Indicator or CDI) that targets a common property of all solid tumours – dead and dying tumour cells. Once these cells have been identified by CDI, therapeutic radiation is then able to be delivered to adjacent viable and growing tumour cells to kill them.

Professor Mathew Vadas AO, Executive Director of the Centenary Institute said the ACRF grant was a fantastic outcome for cancer research in Australia as it pioneered a totally new modality of treating cancer.

“This exciting new initiative will be applicable as a treatment for many types of cancers. We believe this new and technologically advanced laboratory will operate at the very forefront of the burgeoning personalised medicine research field in NSW and beyond,” said Professor Vadas.

Research projects at the new ACRF Molecular Theranostics Laboratory are set to also include the investigation of a new theranostic for the treatment of liver tumours and the development of new chelator-antibody complexes (agents that help carry the therapeutic isotope to the cancer cell).

Themes

  • Cancer

    Cancer

Programs

  • ACRF Centenary Cancer Research Centre

People

  • Professor Philip Hogg

    Deputy Director, Centenary Institute Head
    ACRF Centenary Cancer Research Centre

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

New precision medicine laboratory to help fight cancer

Download

Recent Stories

  • Inflammation presentation awarded

    Dr Joyce Chiu from the ACRF Centenary Cancer Research Centre has won an Oral Communication Award for her talk given at the 15th World Congress on Inflammation, held in Rome, June 2022.
    News Type: Research News
    Date 01 Jul 2022
  • Meet Dr Annalicia Vaughan

    A medical researcher at the Centenary UTS Centre for Inflammation, Dr Annalicia Vaughan specialises in the gut-lung axis and its role in lung and respiratory diseases.
    News Type: Profiles
    Date 28 Jun 2022
    Dr Vaughan
  • The Centenary Institute is excited to join the Sydney Biomedical Accelerator (SBA) as primary medical research partner

    The Centenary Institute welcomes the NSW Government’s commitment to fund a new biomedical complex in Camperdown. The Chair of the Centenary Institute Board, Joseph Carrozzi AM, and its Executive Director, Professor Mathew Vadas AO, are thrilled that a biomedical complex, the Sydney Biomedical Accelerator (SBA), will now be a reality.
    News Type: Media release
    Date 17 Jun 2022
  • Innovation Week –  Getting to the heart of sudden death

    Professor Chis Semsarian AM, Head of the Agnes Ginges Centre for Molecular Cardiology at the Centenary Institute and Cardiologist at the Royal Prince Alfred Hospital, has given a headline talk on the genetic basis of cardiovascular disease as a part of Sydney Local Health District’s 'Innovation Week' event.
    News Type: Research News
    Date 03 Jun 2022

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Laboratories
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram